Lemzoparlimab
Lemzoparlimab Basic information
- Product Name:
- Lemzoparlimab
- Synonyms:
-
- Lemzoparlimab
- Research Grade Lemzoparlimab(DHG17603)
- Lemzoparlimab (anti-CD47)
- Research Grade Lemzoparlimab
- CAS:
- 2377483-71-9
- MW:
- 0
- Mol File:
- Mol File
More
Less
Lemzoparlimab Chemical Properties
- form
- Liquid
- color
- Colorless to light yellow
More
Less
Lemzoparlimab Usage And Synthesis
Uses
Lemzoparlimab (TJ011133; TJC4) is a humanized anti-CD47 IgG4 antibody. Lemzoparlimab has a strong anti-tumor activity[1].
References
[1] Amitkumar Mehta, et al. Lemzoparlimab, a Differentiated Anti-CD47 Antibody in Combination with Rituximab in Relapsed and Refractory Non-Hodgkin's Lymphoma: Initial Clinical Results. Blood (2021) 138 (Supplement 1): 3542.
LemzoparlimabSupplier
Shanghai YuanYe Biotechnology Co., Ltd.
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
Guangzhou Hongyuan Chemical Co.,Ltd
- Tel
- 15817493340
- 981810490@qq.com
Wuhan Chemstan Biotechnology Co., Ltd.
- Tel
- 027-65317797 15926423062
- 422450190@qq.com
TargetMol Chemicals Inc.
- Tel
- 4008200310
- marketing@tsbiochem.com
Biolab Reagents
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com